Retinal hemangioblastoma in von Hippel-Lindau disease: A clinical and molecular study

Investigative Ophthalmology and Visual Science

Volumn 43, Issue 9, 2002, Pages 3067-3074

  Dollfus, Hélène ^a   Massin, Pascale ^a   Taupin, Pierre ^a   Nemeth, Catherine ^a   Amara, Sandrine ^a   Giraud, Sophie ^a   Béroud, Christophe ^a   Dureau, Pascal ^a   Gaudric, Alain ^a   Landais, Paul ^a   Richard, Stéphane ^a  

^a HÔPITAL DE HAUTEPIERRE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; BINDING SITE; CHILD; CONTROLLED STUDY; GENE MUTATION; GENETIC ANALYSIS; GENOTYPE; GENOTYPE PHENOTYPE CORRELATION; GERM LINE; HEMANGIOBLASTOMA; HUMAN; MAJOR CLINICAL STUDY; MORBIDITY; POISSON DISTRIBUTION; PRIORITY JOURNAL; RETINA HEMANGIOBLASTOMA; RETROSPECTIVE STUDY; SEQUENCE ANALYSIS; VISUAL IMPAIRMENT; VON HIPPEL LINDAU DISEASE;

ADOLESCENT; ADULT; BLOTTING, SOUTHERN; CHILD; DNA MUTATIONAL ANALYSIS; FLUORESCEIN ANGIOGRAPHY; FUNDUS OCULI; GENOTYPE; HEMANGIOBLASTOMA; HIPPEL-LINDAU DISEASE; HUMANS; IN SITU HYBRIDIZATION; LIGASES; MIDDLE AGED; PHENOTYPE; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; RETINAL NEOPLASMS; RETROSPECTIVE STUDIES; TUMOR SUPPRESSOR PROTEINS; UBIQUITIN-PROTEIN LIGASES; VON HIPPEL-LINDAU TUMOR SUPPRESSOR PROTEIN;

EID: 0036727853     PISSN: 01460404     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (50)

1. Ueber eine sehr seltene erkrankung der netzhaut
2. Von Hippel-Lindau disease affecting 43 members of a single kindred
3. Clinical features and natural history of von Hippel-Lindau disease
4. Clinical features and molecular genetics of von Hippel-Lindau disease
5. Haemangioblastoma of the central nervous system in von Hippel-Lindau disease
6. Central nervous system hemangioblastomas, endolymphatic sac tumors and von Hippel-Lindau disease
7. Von Hippel-Lindau disease: Clinical and molecular perspectives
8. Von Hippel-Lindau syndrome
9. A genetic register for von Hippel-Lindau disease
10. Haemangioblastoma, haemangioblastomatosis, and von Hippel-Lindau disease
11. Pathology, genetics and cell biology of hemangioblastomas
12. Retinal hemangioblastoma: A histologic, immunohistochemical, and ultrastructural evaluation
13. The eye in von Hippel-Lindau disease: Long term follow-up of screening and treatment-recommendations
14. An analysis of phenotypic variation in the familial cancer syndrome von Hippel-Lindau disease: Evidence for modifier effects
15. The clinical characteristics of ocular angiomatosis in von Hippel-Lindau disease and correlation with germline mutation
16. Ophthalmological screening for von Hippel-Lindau disease
17. Long-term results of laser treatment for retinal angiomatosis in von Hippel-Lindau disease
18. Identification of the von Hippel-Lindau disease tumor suppressor gene
19. Identification of intragenic mutations in the von Hippel-Lindau disease tumor suppressor gene and correlation with disease phenotype
20. Germline mutations in the von Hippel-Lindau tumor suppressor gene: Correlations with phenotype
21. Genotype-phenotype correlation in von Hippel-Lindau disease: Identification of a mutation associated with VHL type 2A
22. Germline mutations in the Von Hippel-Lindau disease (VHL) gene in families from North America, Europe, and Japan
23. Germline mutation profile of the VHL gene in von Hippel-Lindau disease and in sporadic hemangioblastoma
24. Improved detection of germline mutations in the von Hippel-Lindau disease tumor suppressor gene
25. Molecular genetic analysis of von Hippel-Lindau disease
26. Software and database for the analysis of mutations in the VHL gene
27. Meeting report: Third International Symposium on von Hippel-Lindau disease
28. Tumor suppression by the human von Hippel-Lindau gene product
29. Negative regulation of hypoxia-inducible genes by the von Hippel-Lindau protein
30. The VHL tumor-suppressor gene paradigm
31. Rbx1, a component of the VHL tumor suppressor complex and SCF ubiquitin ligase
32. Identification of the von Hippel-Lindau tumor-suppressor protein as part of an active E3 ubiquitin ligase complex
33. VHL: A very hip ligase
34. An important von Hippel-Lindau tumor suppressor domain mediates Sp1-binding and self-association
35. Hypoxia-inducible protein binding to vascular endothelial growth factor mRNA and its modulation by the von Hippel-Lindau protein
36. The von Hippel-Lindau tumor suppressor gene product interacts with Sp1 to repress vascular endothelial growth factor promoter activity
37. The von Hippel-Lindau tumorsuppressor gene product forms a stable complex with human CUL-2, a member of the Cdc53 family of proteins
38. Coexpression of erythropoietin and vascular endothelial growth factor in nervous system tumors associated with von Hippel-Lindau tumor suppressor gene loss of function
39. Regulation of hypoxia-inducible mRNAs by the von Hippel-Lindau tumor suppressor protein requires binding to complexes containing elongins B/C and Cul2
40. The tumor suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis
41. Synthetic peptides define critical contacts between elongin C, elongin B, and the von Hippel-Lindau protein
42. The von Hippel-Lindau tumor suppressor protein: New perspectives
43. VHL gene deletion and enhanced VEGF gene expression detected in the stromal cells of retinal angioma
44. Von Hippel-Lindau (VHL) disease with pheochromocytoma in the Black Forest region of Germany: Evidence for a founder effect
45. Isolated familial pheochromocytoma as a variant of von Hippel-Lindau disease
46. Mutations of the VHL gene in sporadic renal cell carcinoma: Definition of a risk factor for VHL patients to develop a RCC
47. Hemangioblastomas of the retina: Impact of Von Hippel-Lindau disease
48. Two distinct phenotypes caused by two different missense mutations in the same codon of the VHL gene
49. Clinical and genetic characterization of pheochromocytoma in von Hippel-Lindau families: Comparison with sporadic pheochromocytoma gives insight into natural history of pheochromocytoma